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bstract
Polyporus  umbellatus  (formerly Grifola  umbellatus), an edible fungus, has been used as traditional Chinese medicine. The present investigation
imed to uncover the active ingredients in this fungal species, with the emphasis on its polysaccharides. Two polysaccharides, one from fermented
ycelium and the other from the fruiting body, were chromatographically purified. Molecular weights, anti-microbial and immune activities of
he polysaccharides were determined. The mycelium polysaccharide was found to have a molecular weight of 857 kDa and consist of glucose and
alactose at a molar ratio of 1.57:1, while the one from the fruiting body, 679 kDa in molecular weight, was also made up of glucose and galactose
ut at a molar ratio of 5.42:1. In immune assays, these fungal polysaccharides increased the killing potency of natural killer (NK) and lymphokine-
ctivated killer (LAK) cells from mouse spleen and promoted proliferation of mouse B and T cells. Additionally, both P.  umbellatus  mycelium
nd its extract were found to inhibit Escherichia  coli  and Staphylococcus  aureus, but had no effects on Aspergillus  niger  or Aspergillus  nidulans.
hese results indicated that fermented P.  umbellatus  mycelium is indeed immune active, most probably due to its ingredients of polysaccharides.
he consumption of this fungus may be beneficial for human health.
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.  Introduction
Fungal polysaccharide, a kind of active organic compound, is
ound in the mycelium, fruiting bodies, and fermentation broth
f large medicinal and edible fungi [1]. In recent years, polysac-
harides derived from fungi have become an important source of
ioactive substances. A polysaccharide from the fungus, Poly-
orus umbellatus, a polymer of glucose primarily linked by
 (1 →  3) glycosidic bond, has been shown to be capable of
ecimating tumor cells [2]. Further investigations revealed that
he tertiary structure, rather than the primary structure, is the
ajor determinant of the pharmacological activities of this fun-
al polysaccharide. It has been suggested that a polysaccharide∗ Corresponding author at: Tel.: +86 21 60873190; fax: +86 21 54487207.
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ith both β  (1 →  3) and β  (1 →  6) or with both β  (1 →  4)
nd β (1 →  6) glycosidic bonds, instead of purely β  (1 →  4)
lycosidic bond, is generally more pharmacologically active
3,4].
The structures of polysaccharides from several edible and
harmacologically active fungi have been elucidated. The main
hain of lentinan polysaccharide is linked by β  (1 →  3) glyco-
idic bond, while the side chains branch out at C6. There are three
ypes of side chains, namely, side chains with β  (1 →  6) glyco-
idic bond only, short side chains with β  (1 →  3) glycosidic bond
nly and side chains with a non-reducing end [5]. The polysac-
haride of fruiting body from the glossy ganoderma, Ganoderma
ucidum, is made up of fucose, xylose and mannose at a molar
atio of 1:1:1. The main chain is a polymer of D-mannose linked
y (1 →  4) glycosidic bond, and the side chains, which are poly-
ers of fucose and xylose, branch out at C3 of the mannose on
he main chain [2]. The insoluble polysaccharide from the Chi-
ese caterpillar fungus, Cordyceps  sinensis, is a glucosan with
 molecular weight of 632 kDa [2], while the acidic tremellan
onsists of a main chain made up of mannose linked by α (1 →  3)
nd side chains that are polymers of glucuronic acid and xylose
6]. However, to our best knowledge, there has been no report on
iochemical properties of the polysaccharide from the mycelium
f P.  umbellatus.
















































Treatment scheme for immune assays.
Group Number of mice Feeding dosea
Saline (blank) 3 0.2 mL/each
CTX inhibition control 3 0.6 mg/each
Single formula 3 100 g/each
Mixed formula (high-dose) 3 500 g/each
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The anti-microbial activities of extracts from fermented
ungi have been reported for numerous fungal species, such
s Cordyceps  sinensis  [7], Ganodorma  lucidum  [8], and Lac-
arius deliciosus  [9]. However, very little is known about the
nti-microbial activities or pharmacological activities of extracts
f fermented mycelium of P.  umbellatus. Hence, the objectives
f the present investigation were to characterize the biochem-
cal properties of polysaccharides purified from the mycelium
nd fruiting body of P.  umbellatus  and test anti-microbial and
mmune activities of these polysaccharides.
.  Materials  and  methods
.1.  Preparation  of  polysaccharides
P.  umbellatus  was obtained from the Institute of Microbiol-
gy, Chinese Academy of Sciences. The fungus was cultured
n a medium (75 mL) containing 3% glucose, 2% broth, 0.2%
east extract, 0.15% MgSO4, and 0.3% KH2PO4 and at pH 5.5.
he fungus culture was incubated at 90 r/min and 25 ◦C for 4
. In order to extract polysaccharides, P.  umbellatus  (both the
ycelium and fruiting body) was mixed with water at a mass
atio of 1:15. This mixture was treated with a VC 750 ultra-
onic processor (Sonics & Materials Inc., Newton, CT, USA) for
5 min to disrupt the cells. The ultrasonic power and frequency
ere 500 W and 18 kHz, respectively. Then, an equal volume of
ot water (98 ◦C) was added and the mixture was incubated at
8 ◦C for 1.5 h. Polysaccharides were precipitated by the addi-
ion of ethanol (final concentration 80%, v/v). The crude extract
f fungal polysaccharides was dried, and the polysaccharides
ontent was assayed using the phenol–sulfuric acid method [10].
.2.  Puriﬁcation  of  polysaccharides
The crude polysaccharides were dissolved in water at a
oncentration of 0.5 g/L. This solution was then chromatograph-
cally resolved with Sephadex G-100 (Pharmacia, Swedish)
t an elution rate of 0.5 mL/min. The presence of polysac-
harides was detected using the phenol–sulfuric acid method.
he elution fractions containing purified polysaccharides were
reeze-dried for 24 h. Two polysaccharides, symbolized as PUm-
 and PUf-C, were obtained. These two polysaccharides were
rst hydrolyzed by trifluoroacetic acid (TFA), and then the
ydrolysis products were resolved by HPLC (LC-20A, Shi-
adzu, Japan) to characterize monosaccharide components.
dditionally, the molecular weights of these two polysaccha-
ides were determined using HPLC (LC-20A, Shimadzu, Japan).
he conditions were injection volume: 20 L; mobile phase:
 mmol/L NaAc; flow rate: 0.5 mL/min. The molecular weights
ere then calculated by reference to the calibration curve made
sing standard dextrans (Sigma–Aldrich, St. Louis, MO, USA)
ith known molecular weights..3.  Immune  activities
Male mice (age 5–6 weeks) purchased from the Institute of




Aixed formula (low-dose) 3 50 g/each
The mice were fed on day 1, 7 and 14.
ormula containing mycelium polysaccharides of P.  umbellatus
r a mixed formula with three fungal polysaccharides from P.
mbellatus,  Ganoderma  lucidum  and Cordyceps  sinensis  at a
ass ratio of 8:1:1 (Table 1). The control animals were given
yclophosphamide (CTX) (Jiangsu Hengrui Medicine Co., Ltd.,
iangsu, China). At the end of the treatment (day 15), mice were
acrificed and the spleen was dissected under sterile condition.
he spleen was then crushed and lymph cells were obtained with
icoll (density 1.088). These cells included T cells, B cells, nat-
ral killer (NK) cells and lymphokine-activated killer (LAK)
ells. The induction of LAK cells was carried out according
o the method of Zhuang et al. [11]. Spleen lymph cells were
ultured in a medium containing 10% FCS1640 and 500 U/mL
L-2 for 24 h. Cytotoxicity assay was conducted using the MTT
olorimetric method as described by Cai [12]. The YAC mouse
eukemia cells, P815 Mouse mast leukemia cells, Lewis lung
ancer cells and HAC liver cancer cells were used as target
ells. To investigate the impact of dietary administration of fun-
al polysaccharides on lymph cell proliferation, 200 L spleen
xtract containing 2 ×  106 cells was introduced to the 96-well
lates. T cells and B cells were sensitized with 5 g/mL ConA
Sigma–Aldrich, St. Louis, MO, USA) or 5 g/mL lipid polysac-
haride (LPS; Sigma–Aldrich, St. Louis, MO, USA) (n  Y = 5).
ontrol cells were not treated with ConA or LPS. Both B and
 cells were cultured at 37 ◦C and 5% CO2 for 3 d for ConA-
reated cells, and 5 d for LPS-treated cells. Sixteen hours before
he termination of the treatment, 3H-tritiated thymidine (TdR)
as added to each well. Cells were collected with a filter paper,
nd then treated with 0.5 mL scintillation solution. The amount
f radiation in count per minute (CPM) was determined with
 scintillation counter (Model XH-6925, Shanghai Precision
nstrument Co., Ltd., China). The stimulation index (SI) and
he ratio between the CPMs of treated and control cells were
etermined.
.4.  Anti-microbial  activities
Two methods were used to test anti-microbial activities of P.
mbellatus extract. In one method, blocks of fermented mycelia
ere placed on the nutrient broth (NB) or potato dextrose agar
PDA) mixed with 0.1 mL tested bacteria- or molds-containing
ulture. The other was the double-layer plate method, wherein
he lower layer of the medium contained NB for bacteria
nd PDA for fungi, while the upper layer was a mixture of
oft agar and 0.1 mL bacteria- or molds-containing culture.
fter agar became solidified, holes were drilled, and 1 mL the
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NFig. 1. Elution profiles of polysaccharides from th
olysaccharide extract from fermented mycelium was added.
he size of inhibition zone was measured after 20 h and 48 h.
orfloxacin was used as a positive control.
.5.  Data  analysis
Data are expressed as the means ±  standard deviation. Dun-
ett’s t-test (SAS 8.0) was used to analyze the results. A P-value
f less than 0.05 was considered significant.
.  Results  and  discussion
The elution profile was shown in Fig. 1. UV scan at 260 nm
nd 280 nm exhibited no absorption, suggesting that there was no
ucleic acids or proteins. HPLC analysis of hydrolysis products
f these two polysaccharides (Fig. 2) showed that the polysac-
haride from the fruiting body of P.  umbellatus  consisted of





illing activities of NK cells and LAK cells.
reatment Killing rate (%)
YAC-1 P815 
NK LAK NK LAK 
aline (blank) 34.04 ± 2.04 32.84 ± 1.20 13.06 ± 0.78* 26.53 ± 0.
TX inhibition
control
22.08 ± 1.53* 27.25 ± 1.06* 10.63 ± 0.85* 19.94 ± 1.
ingle formula 23.85 ± 2.62* 33.23 ± 0.89 19.00 ± 0.99* 13.76 ± 1.
ixed formula
high-dose
35.61 ± 0.85 33.57 ± 2.19 21.77 ± 1.06 23.77 ± 1.
ixed formula
medium-dose
31.45 ± 1.34 33.09 ± 1.56 16.70 ± 1.70* 18.50 ± 2.
ixed formula
low-dose
25.72 ± 1.56* 35.53 ± 2.12 16.12 ± 0.85* 19.83 ± 1.
ote: Data represent mean ± standard deviation.
* Significant at P < 0.05. Similarly hereinafter unless otherwise stated.celium (a) and fruiting body (b) of P. umbellatus.
rom mycelium of this fungus was also made up of glucose
nd galactose but at a molar ratio of 1.57:1. The molecular
eights of these two polysaccharides were 679 kDa for the one
rom the fruiting body and 857 kDa for mycelium polysaccha-
ide according to the HPLC results (Fig. 3). It has been noted
hat the anti-tumorogenicity of a polysaccharide is related to its
olecular weight, with the minimum molecular weight for anti-
umorogenicity of 10 kDa [2]. The molecular weights of the two
olysaccharides were greater than 10 kDa, suggesting that these
wo fungal polysaccharides may possess anti-tumor activity.
NK and LAK cells play an important role in immune defense.
n the present investigation, alterations in the potency of these
ells in killing NK-specific target cells (YAC-1 cells), NK-non-
pecific cells (P815), Lewis lung cancer cells (Lewis) and liver
ancer cells (HAC) after dietary treatments with P.  umbellatus
olysaccharides were examined. The potency in killing P815
ells of NK cells from mice fed with the single formula con-
aining P.  umbellatus  polysaccharide was 19%, greater than that
Lewis HAC
NK LAK NK LAK
78 27.50 ± 0.71 32.86 ± 1.20 28.33 ± 0.49 30.46 ± 2.19
34* 21.74 ± 1.77* 26.12 ± 1.56* 18.35 ± 0.92* 21.05 ± 1.13*
06* 19.04 ± 1.06* 33.01 ± 1.41 17.68 ± 0.99* 23.26 ± 0.61*
34 21.46 ± 1.34* 28.55 ± 2.19 19.89 ± 1.27* 26.99 ± 2.83
12* 19.26 ± 1.77* 33.03 ± 1.48 13.07 ± 0.64* 21.83 ± 1.17*
91* 13.63 ± 0.92* 31.65 ± 0.78 17.06 ± 1.49* 20.01 ± 1.15*
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Table 3
Multiplication activation of T and B-lymphocytes as indicated by the stimulation index (SI).
Group CPM SI CPM SI
Control ConA Control LPS
Saline (blank) 120 ± 67 49,676 ± 2459* 129 ± 35 4287 ± 947*
CTX inhibition control 1620 ± 608 28,992 ± 7227* 1.0 1648 ± 238 2271 ± 953 1.0
Single formula 792 ± 392 60,411 ± 2789* 2.2 482 ± 621 4330 ± 257* 1.5
Mixed formula (high-dose) 2425 ± 1160 32,485 ± 10,545* 1.1 872 ± 621 4732 ± 2508* 1.8
Mixed formula (medium-dose) 2279 ± 893 42,763 ± 3699* 1.3 878 ± 383 5089 ± 629* 1.3
Mixed formula (low-dose) 1112 ± 612 79,556 ± 9230* 2.9 3200 ± 1065 3126 ± 913 1.1
* Significant at P < 0.05.
Fig. 2. HPLC spectra of hydrolysis products of polysaccharides from mycelium
(PUm-C) and fruiting body (PUf-C).
Table 4
Anti-microbial activities of fermented mycelium of P. umbellatus as indicated
by the size (diameter in cm) of the inhibition zone.
Inhibition zone Dilution
10−1 10−2 10−3
Control +++ +++ +++
Escherichia coli (20 h) 3.9 ± 0.1 4.5 ± 0.3 +++
Staphylococcus aureus (20 h) 4.2 ± 0.1* 5.0 ± 0.2* +++
Aspergillus niger (24 h) − − −
Aspergillus nidulans (48 h) − − −





























w6 cm. Similarly hereinafter.
* Significant at P < 0.05.
f the blank group (13.06%) (Table 2). In other words, dietary
reatments with the mycelium polysaccharide resulted in a 60%
ncrease in the killing potency of NK cells. But this dose of
ycelium polysaccharide had no effect on the killing potency
f LAK cells. Dietary treatments with three doses of the mixture
ormula resulted in greater P815-killing potencies of LAK rela-
ive to the control, with the highest dose being the most potent
Table 2). Treatments with polysaccharide mixture increased
he potency of LAK cells in killing HAC, Lewis and YAC-1 in
 dose-response manner. These results strongly suggest that P.
mbellatus polysaccharides, when given alone or in mixture with
ther fungal polysaccharides, increase the activity of immune
ells.
Results of cell proliferation experiment (Table 3) showed that
ietary treatments with P.  umbellatus  polysaccharides alone or in
ombination with other polysaccharides resulted in an increase
n SI value, suggesting that these fungal polysaccharides are
apable of stimulating proliferation of T and B cells.
As shown in Table 4, the fermented mycelium of P.  umbel-
atus was found to be capable of inhibiting the proliferation of
scherichia  coli  and Staphylococcus  aureus  with the size of
nhibition zone increasing with the dilution of the seed bacteria.
reatments with the fermented P.  umbellatus  had no effect on
he growth of Aspergillus  niger  or A.  nidulans. The antibacte-
ial activity of P.  umbellatus  mycelium was further supported
y the additional results that the polysaccharide extract of P.
mbellatus mycelium was also capable of inhibiting bacterial
roliferation, with the size of inhibition zone increasing when
he dilution of the seed bacteria (Table 5). But this fungal extract
as inactive on either A.  niger  or A.  nidulans. Similarly, Hou
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Fig. 3. HPLC spectra of polysaccharides from my
Table 5
Anti-microbial activities of extraction from polysaccharides of P. umbellatus as
indicated by the size (diameter in cm) of the inhibition zone.
Inhibition zone Dilution
10−1 10−2 10−3
Escherichia coli (20 h) 3.7 ± 0.1 3.9 ± 0.2 +++
Escherichia coli (38 h) 3.2 ± 0.4 3.7 ± 0.1 +++
Staphylococcus aureus (20 h) 4.1 ± 0.3 5.3 ± 0.1 +++
Staphylococcus aureus (38 h) 2.8 ± 0.1 3.9 ± 0.3 +++
Aspergillus niger (24 h) − − −




















37–38.t al. [13] evidenced that a novel polysaccharide (TMP-A) iso-
ated from Tricholoma  matsutake  showed antibacterial activity
gainst E.  coli  and Staphylococcus  albus. And TMP-A did not
xhibit any antifungal activity against target strains, including
. niger.
.  Conclusion
The results of the present study provide experimental evi-
ence that fermented P.  umbellatus  mycelium is indeed immune
ctive, with active ingredients most likely being its polysaccha-
ides, and the consumption of this fungus may be beneficial
or human health. Hence, the polysaccharide productions of P.
mbellatus from the submerged mycelium are worth further
xploration. Nevertheless, further investigations are neces-
ary to determine the anti-tumor and antioxidant activitiescelium (PUm-C) and fruiting body (PUf-C).
f the polysaccharide isolated from fermented P.  umbellatus
ycelium.
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